Sign inJoin waitlistJoin the waitlist

Andrew Galligan

Associate Program Director, Pediatric Residency · University of South Florida Morsani College of Medicine

Credentials: · · · · · ·

History

Pediatric Residency · University of South Florida Morsani College of Medicine
Present
University of South Florida Morsani College of Medicine
Present
University of South Florida Morsani College of Medicine
Present

Pediatric Hematology/Oncology
University of Florida College of Medicine
2011–2014
Pediatrics
University of Florida College of Medicine
2008–2011
The Florida State Univ Coll of Med
2004–2008

Research

Childhood Cancer Survivorship and Long-Term Outcomes
Advances in Pediatrics · 2017 · Sole author · 24 citations
Sink or Collaborate: How the Immersive Model Has Helped Address Typical Adolescent and Young Adult Barriers at a Single Institution and Kept the Adolescent and Young Adult Program…
Journal of Adolescent and Young Adult Oncology · 2017 · 15 citations
Family dynamics in young adult cancer caregiving: "It should be teamwork"
Journal of Psychosocial Oncology · 2019 · 9 citations

Umberto Donato
6 papers
DR
Damon Reed
5 papers
BO
Benjamin Oshrine
3 papers
BS
Bijal Shah
3 papers
AS
Ahmad Shaker
2 papers
AT
Akaluck Thatayatikom
2 papers
AA
Alfred Asante-Korang
2 papers
AS
Amanda Schlefman
2 papers
Celeste Shoeleh
2 papers
Dana Obzut
2 papers
Danielle Tometich
2 papers
DM
Diana Milojevic
2 papers

Clinical trials

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2031
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2022–2031
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2020–2028